tradingkey.logo
搜尋

Haemonetics Corp

HAE
添加自選
85.540USD
+0.780+0.92%
收盤 07-31 16:00美東報價延遲15分鐘
3.87B總市值
41.47本益比TTM

關於 Haemonetics Corp 公司

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.

Haemonetics Corp簡介

公司代碼HAE
公司名稱Haemonetics Corp
上市日期Oct 17, 1979
CEOSimon (Christopher A)
員工數量3023
證券類型Ordinary Share
年結日Oct 17
公司地址125 Summer Street
城市BOSTON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編02110
電話17818487100
網址https://www.haemonetics.com
公司代碼HAE
上市日期Oct 17, 1979
CEOSimon (Christopher A)

Haemonetics Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
--
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
--
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
-5.99%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
--
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
--
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
--
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
7.00K
+53.66%
Mr. Christopher A. Simon
Mr. Christopher A. Simon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
--
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
--
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
-5.99%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
--

常見問題

Haemonetics Corp的前五大股東是誰?

Haemonetics Corp的前五大股東如下:Ms. Laurie A. Miller

有多少機構持有Haemonetics Corp(HAE)的股份?

截至2026Q1,共有737家機構持有Haemonetics Corp的股份,合計持有的股份價值約為58.91M,占公司總股份的126.77% 。與2025Q4相比,機構持股有所增加,增幅為664078.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有